Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

TheMotleyFool

0 0

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stock has been a huge winner in the past. A $10,000 investment in the biotech 10 years ago would be worth more than $200,000 today. Regeneron's shareholders have been on a roller-coaster ride, though, with the stock plunging in 2016 but bouncing back somewhat this year.

What Regeneron has done in the past isn't nearly as important to investors as what the biotech could do in the future. Is the stock now a buy? Here are the arguments for and against Regeneron.

Image source: Getty Images.

Source: Fool.com